WorldPing logo WorldPing← All news

STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and moreWorldPing
Image via STAT.

What happened

The U.S.approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers…

Key facts

  • The U.S.approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of upfront discounts, to certain providers…
  • Reported by STAT and published Fri, 02 Oct 2026 13:11:16 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Washington Post
WorldPing
Washington Post

FlyDubai co-pilot used crash ax to attempt terrorist act, UAE says

The alleged attacker, Hamam al-Hammami, had been banned from flying with Oman Air because of concerns about his radical views, a person familiar with the matter said.

Brief by WorldPing · Original reporting by Washington Post